Radical Numerics launches with $50M to build general biological intelligence

2026-06-15 · Source: AI – SiliconANGLE · Field: Technology & Digital — Artificial Intelligence & Machine Learning, Emerging Technologies & Innovation, Computational Biology & Genomics · Depth: Expert, quick

Summary

Radical Numerics Inc., an artificial intelligence research lab, launched on June 15, 2026, with \$50 million in funding to develop "general biological intelligence." The company aims to build models that learn directly from diverse biological data, including DNA, RNA, and proteins, integrating these into a single system. Founded by the team behind Evo and Evo 2, which were the first AI models to read and write DNA at large scale and generated the first complete AI-designed genome, Radical Numerics is now previewing Omnii. This next-generation genomic language model reportedly achieves new benchmarks in identifying causal regulatory variants and zero-shot transfer to experimental settings, including recovering Alzheimer's disease-related functional variants and detecting AI-generated pathogens. The company operates with a dual mandate: advancing biological design for human health, such as cancer diagnostics and drug target identification, while simultaneously building biosecurity defenses.

Key takeaway

For AI Scientists and Directors of AI/ML evaluating next-generation biological intelligence, Radical Numerics' multimodal approach with Omnii suggests a shift towards integrated biological data systems. Your teams should consider the dual-use implications of such powerful models, planning for both advanced health applications like cancer diagnostics and robust biosecurity defenses against engineered pathogens. Prioritize research into models that can simultaneously advance design and detect threats.

Key insights

Multimodal AI models integrating diverse biological data can advance human health through diagnostics and drug discovery while simultaneously bolstering biosecurity.

Principles

• Multimodal biological AI surpasses single-modality limits.
• Biological AI inherently presents dual-use capabilities.

Method

Radical Numerics builds models by integrating diverse biological data (DNA, RNA, proteins) into a single system, enabling multimodal reasoning across all biological dimensions simultaneously.

In practice

• Identify causal regulatory variants.
• Detect AI-generated or manipulated pathogens.
• Aid in cancer diagnostics and drug discovery.

Topics

• General Biological Intelligence
• Multimodal AI
• Genomic Language Models
• Biosecurity
• Cancer Diagnostics
• Pathogen Detection

Best for: CTO, Investor, AI Scientist, Research Scientist, Director of AI/ML

Related on AIssential

• Artificial intelligence and biology: AI’s potential for launching a novel era for health and medicine — AI is transforming biology by enabling large-scale analysis of complex interactions, moving towards causal understanding.
• Applying multimodal biological foundation models across therapeutics and patient care — Multimodal BioFMs integrate diverse biological data to significantly enhance healthcare decision-making and therapeutic development.
• Immunotherapy drug target identification using machine learning and patient-derived tumour explant validation — MIDAS, a multimodal GNN, effectively identifies novel immuno-oncology targets by integrating diverse biological data.
• Why Specialist Models Still Matter: A Heterogeneous Multi-Agent Paradigm for Medical Artificial Intelligence — The future of medical AI lies in orchestrating generalist LLMs, specialist models, and clinicians through multi-agent collaboration.
• Generalizable mutation-effect prediction across adaptive immune recognition via unified multimodal framework — UniAIR unifies multimodal data and structural information to predict immune mutation effects with high generalizability.
• AI can design viruses, toxins and other bioweapons. How worried should we be? — AI tools in biology present a dual-use dilemma, offering drug discovery benefits while raising bioweapon design and proliferation risks.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by AI – SiliconANGLE.